Zim Laboratories MD, chairman, board of directors and AGM
NSE: ZIMLABBSE: 541400Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹132.12.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹677 Cr1,933rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 183.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,16,71445.7% delivered
Zim Laboratories board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorAnwar DaudRelated to the promoter
- Company Secretary and Compliance OfficerPiyush Nikhade
8 directors4 independent4 executive
- Anwar Daud · Chairperson and managing directorExecutive · joined Jun 2002 · reappointed Aug 2022 · 1 listed board
- Zulfiquar Murtuza KamalExecutive · joined Oct 2012 · reappointed Oct 2022 · 1 listed board · 1 committee seat
- Niraj Pukhraj DhadiwalExecutive · joined Nov 2013 · reappointed Oct 2025 · 1 listed board
- Prakash Pralahadrao SapkalExecutive · joined Nov 2013 · reappointed Oct 2025 · 1 listed board · 1 committee seat
- Kavita LoyaIndependent · joined Sep 2017 · reappointed Sep 2022 · 108 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- Padmakar Shrinivas JoshiIndependent · joined Sep 2017 · reappointed Sep 2022 · 108 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Kamlesh Bajirao ShendeIndependent · joined Apr 2022 · reappointed Apr 2025 · 54 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Ashok BhatiaIndependent · joined Apr 2025 · reappointed Apr 2025 · 18 months as independent · 2 listed boards · 2 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 26 Sep 20268 of 8 present4 independent · 14 days in between
- 11 Sep 20268 of 8 present4 independent · 35 days in between
- 6 Aug 20268 of 8 present4 independent · 34 days in between
- 2 Jul 20268 of 8 present4 independent · 43 days in between
2 earlier meetings
- 19 May 20268 of 8 present4 independent
- 5 May 20267 of 8 present3 independent
Audit Committee
Chair Kavita Loya
Padmakar Shrinivas Joshi, Zulfiquar Murtuza Kamal
- 2 Sep 20263 of 3 present2 independent · 27 days in between
- 5 Aug 20263 of 3 present2 independent · 33 days in between
- 2 Jul 20263 of 3 present2 independent · 44 days in between
- 18 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Padmakar Shrinivas Joshi
Kavita Loya, Ashok Bhatia, Anwar Daud
- 11 Sep 20264 of 4 present3 independent · 75 days in between
- 27 Jun 20264 of 4 present3 independent · 8 days in between
- 18 Jun 20264 of 4 present3 independent · 29 days in between
- 19 May 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Kavita Loya
Kamlesh Bajirao Shende, Prakash Pralahadrao Sapkal
No meeting listed in the filing.
Risk Management Committee
Chair Padmakar Shrinivas Joshi
Kamlesh Bajirao Shende, Kavita Loya, Anwar Daud
- 11 Sep 20264 of 4 present3 independent · 10 days in between
Corporate Social Responsibility Committee
Chair Kamlesh Bajirao Shende
Padmakar Shrinivas Joshi, Niraj Pukhraj Dhadiwal
- 31 Aug 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Delloite Hasinks & Sells LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
- Walker Chandiok and Co LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Zim Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Zim Laboratories share news and announcements
Postal ballot, 11 Aug 2026
14,669 shareholders on the register on 3 Jul 2026; votes counted by Roshni Jethani / NA.The company's voting result (opens in a new tab)
- To approve the revision in remuneration structure and payment of remuneration to Dr. Anwar Daud, Managing Director (DIN: 00023529) of the Company.SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 48.25% · promoters 100.00% · institutions 79.12% · other public 24.58%
- To approve the revision in remuneration structure and payment of remuneration to Mr. Zulfiquar Kamal, Whole-Time Director (DIN: 01786763) of the Company.SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 48.25% · promoters 100.00% · institutions 79.12% · other public 24.58%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Jun 2026, 4 resolutions
15,156 shareholders on the register on 22 Jun 2026; present: 4 promoters and 51 others; votes counted by Ms. Roshni Jethani / N.A..The company's voting result (opens in a new tab)
- Consideration and Adoption of Audited Financial Statements of the Company for the Financial Year ended 31st March, 2025 and the report of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 47.41% · promoters 100.00% · other public 24.51%
- To appoint a Director in place of Mr. Zulfiquar Kamal (DIN: 01786763), who retires by rotation and being eligible, offers himself for re-appointment.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 47.41% · promoters 100.00% · other public 24.51%
- To ratify the remuneration payable to M/s Dhananjay V. Joshi & Associates, Cost Auditors, for the Financial Year 2026-27Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 47.41% · promoters 100.00% · other public 24.51%
- Approval for payment of remuneration to the Managing Director and Whole Time Director in case of absence or inadequacy of profits, as per Section II, Part II of Schedule V of the Companies Act, 2013SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 47.41% · promoters 100.00% · other public 24.51%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 16 Feb 2026, 1 resolution
17,128 shareholders on the register on 9 Feb 2026; present: 6 promoters and 36 others; votes counted by Ms. Roshni Jethani / NA.The company's voting result (opens in a new tab)
- ISSUANCE OF EQUITY SHARES OF THE COMPANY BY WAY OF A PREFERENTIAL ISSUE ON A PRIVATE PLACEMENT BASISSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 63.07% · promoters 100.00% · institutions 0.00% · other public 44.67%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 13 Nov 2025, 2 resolutions
17,614 shareholders on the register on 10 Oct 2025; votes counted by Roshni Jethani / NIL.The company's voting result (opens in a new tab)
- To re-appoint Mr. Niraj Dhadiwal (DIN: 02007428) as Whole-time Director of the Company.SpecialPromoters have an interest in it99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 45.80% · promoters 99.74% · institutions 1.08% · other public 18.96%
- To re-appoint Mr. Prakash Sapkal (DIN: 02007385) as Whole time Director of the CompanySpecialPromoters have an interest in it99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 45.80% · promoters 99.74% · institutions 1.08% · other public 18.96%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Jun 2025, 8 resolutions
17,053 shareholders on the register on 20 Jun 2025; present: 5 promoters and 53 others; votes counted by Ms. Roshni Jethani / NA.The company's voting result (opens in a new tab)
- Consideration and Adoption of Audited Financial Statements of the Company for the Financial Year ended 31st March, 2025 and the report of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- To appoint a Director in place of Mr. Zulfiquar Kamal (DIN: 01786763), who retires by rotation and being eligible, offers himself for reappointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- To appoint M/s. Deloitte Haskins & Sells LLP, Chartered Accountants (Firm Registration No. 117366W/W-100018) as the Statutory Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- To ratify the remuneration payable to M/s Dhananjay V. Joshi & Associates, Cost Auditors, for the Financial Year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- To appoint M/s. BNP & Associates (Firm Registration No. P2014MH037400) as the Secretarial Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- To re-appoint Dr. Kamlesh Shende (DIN: 09537666) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- To appoint of Mr. Ashok Bhatia (DIN: 02090239) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
- Approval for payment of remuneration to Independent Directors pursuant to Section II Part II of Schedule V of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.22% · promoters 99.36% · institutions 0.00% · other public 27.23%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Jun 2024, 3 resolutions
Present: 4 promoters and 36 others.The company's voting result (opens in a new tab)
- Consideration and Adoption of Audited Financial Statements of the Company for the Financial Year ended 31st March, 2024 and the report of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.16% · promoters 99.36% · institutions 0.00% · other public 27.13%
- To appoint a Director in place of Mr. Prakash Sapkal (DIN: 02007385), who retires by rotation and being eligible, offers himself for re-appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.16% · promoters 99.36% · institutions 0.00% · other public 27.13%
- Ratification of remuneration payable to M/s Dhananjay V. Joshi & Associates, Cost Auditors, for the Financial Year 2024-25.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.16% · promoters 99.36% · institutions 0.00% · other public 27.13%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 28 Jan 2024, 3 resolutions
The company's voting result (opens in a new tab)
- Approval of ‘ZIM Laboratories Employee Stock Option Scheme 2023’Special99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 51.54% · promoters 100.00% · institutions 0.00% · other public 27.39%
- Approval of grant of employee stock options to the eligible employees of the subsidiary company(ies)of the Company under ‘ZIM Laboratories Employee Stock Option Scheme 2023’Special99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 51.54% · promoters 100.00% · institutions 0.00% · other public 27.39%
- Approval for payment of remuneration to the Managing Director and Whole Time Directors in case of absence or inadequacy of profits, as per Section II, Part II of Schedule V of the Companies Act, 2013Special99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 51.54% · promoters 100.00% · institutions 0.00% · other public 27.39%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 10 Jul 2023, 3 resolutions
Present: 5 promoters and 50 others.The company's voting result (opens in a new tab)
- Consideration and Adoption of Audited Financial Statements of the Company for the FinancialnYear ended 31st March, 2023 and the report of the Board of Directors and Auditors thereon.nnOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 50.32% · promoters 100.00% · institutions 0.00% · other public 25.55%
- Re-appointment of Director in place of retiring DirectornOrdinary99.61% for0.39% against
Against: promoters 0.00% · institutions 0.00% · other public 1.16%
Turnout: all 50.31% · promoters 100.00% · institutions 0.00% · other public 25.55%
- Ratification of remuneration payable to M/s Dhananjay V. Joshi & Associates, Cost Auditors, for the Financial Year 2023-24.nnOrdinary99.61% for0.39% against
Against: promoters 0.00% · institutions 0.00% · other public 1.16%
Turnout: all 50.31% · promoters 100.00% · institutions 0.00% · other public 25.55%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 11 Aug 2026, 1 fund house so far (houses' deadline to file 15 Oct 2026)
- To approve the revision in remuneration structure and payment of remuneration to Dr. Anwar Daud, Managing Director (DIN: 00023529) of the Company.1 for0 against
- To approve the revision in remuneration structure and payment of remuneration to Mr. Zulfiquar Kamal, Whole-Time Director (DIN: 01786763) of the Company.1 for0 against
Mutual fund votes, meeting of 29 Jun 2026, 1 fund house
- Consideration and Adoption of Audited Financial Statements of the Company for the Financial Year ended 31st March, 2025 and the report of the Board of Directors and Auditors thereon.1 for0 against
- To appoint a Director in place of Mr. Zulfiquar Kamal (DIN: 01786763), who retires by rotation and being eligible, offers himself for re-appointment.1 for0 against
- To ratify the remuneration payable to M/s Dhananjay V. Joshi & Associates, Cost Auditors, for the Financial Year 2026-271 for0 against
- Approval for payment of remuneration to the Managing Director and Whole Time Director in case of absence or inadequacy of profits, as per Section II, Part II of Schedule V of the Companies Act, 20131 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines and tax disputes
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyGoods and Service Tax DepartmentSince 23 Jul 2026
The Order passed u/s 107(11) of the MGST Act and the CGST Act) No: - JCST/APP-NAG/GST-298/2025-26/AO/2026_27/ 2/25 Nagpur, Dated-23.07.2026 received imposing to pay demand of Rs. 8,80,862.00 under IGST act,interest of Rs 1,277.00 under IGST, Rs.1,828.00 each under CGST and SGST and to pay penalty of Rs 1,57,951.
Excess ITC claimed by the Company which was not confirmed in GSTR2A . - Fine or penaltyAssistant Commissioner (ST)Since 3 Jul 2026
Issuance of a show cause notice for payment of tax amounting to Rs 30,59,828, along with applicable interest of Rs. 10,07,982 and a penalty of Rs. 3,05,982, on account of suppression of outward supplies for the period April 2023 to March 2024. The differential tax liability along with applicable interest was voluntarily paid and no further tax remains recoverable hence,the proceedings initiated through the Show Cause Notice are dropped
The company was alleged to have underreported outward supplies in GSTR-1 and GSTR-3B for April 2023–March 2024, resulting in suppressed taxable value and short payment of GST. - Tax disputeDCIT (Deputy Commissioner of Income Tax)Since 21 Dec 2017
Demand order no. 17/07/2017-18 dated 21-12-2017 received for demand of INR 395.95 lakhs for A.Y. 2010-11. Appeal filed with CIT Appeal on 16 Jan 2018. Stay for the Demand is granted by CIT(A) vide order dated 17-01-2022.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far. A statement's amounts are left out where the raise it states is more than ten times everything the company owns, a figure typed at the wrong scale.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesMar 2026 | – | 0 | – | – | No |